Oral colonization by Candida species in AIDS pediatric patients

Oral Diseases

Volumn 17, Issue 4, 2011, Pages 393-398

  Domaneschi, C ^a   Massarente, Db ^a   de Freitas, Rs ^a   de Sousa Marques, Hh ^a   Paula, Cr ^a   Migliari, Da ^a   Antunes, Jlf ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Candida spp; Dental caries; HIV infection; Sociodemographic condition

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFANILAMIDE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; CHILD; CONTROLLED STUDY; DENTAL CARIES; FEMALE; FUNGAL COLONIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH LESION; NONHUMAN; PEDIATRICS; PREVALENCE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 79953764339     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01765.x     Document Type: Article

References (34)

1. Aguirre JM, Echebarria MA, Eguia-Del Valle A (2004). Síndrome de immunodeficiencia adquirida: manifestaciones en la cavidad bucal. Med Oral Patol Oral Cir Bucal 9: 148-157.
2. Ahmad S, Khan Z, Mokaddas E, Khan ZA (2004). Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53: 633-637.
3. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R (2005). Prevalence of Candida dubliniensis among germ tubepositive Candida isolates in a maternity hospital in Kuwait. Mycoses 48: 347-351.
4. Alves SH, Milan EP, de Laet Sant'Ana P, Oliveira LO, Santurio JM, Colombo AL (2002). Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis 43: 85-86.
5. Arikan S, Darka O, Hascelik G, Gunalp A (2003). Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods. Mikrobiyol Bul 37: 49-57.
6. Barros AJD, Hirakata VN (2003). lternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
7. Bretz WA, Flaitz C, Moretti A, Corby P, Schneider LG, Nichols CM (2000). Medication usage and dental caries outcome-related variables in HIV/AIDS patients. AIDS Patient Care STDS 14: 549-554.
8. Brown DM, Jabra-Rizk MA, Falkler WA Jr, Baqui AA, Meiller TF (2000). Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr Dent 22: 234-238.
9. Castro GF, Souza IPR, Oliveira RHS, Portela MB, Esteves C (2001). Prevalência de cárie e sua correlação com a classificação clínica e imunológica em crianças infectadas pelo HIV. Pesqui Odontol Bras 15: 91-97.
10. Cauda R, Facconelli E, Tumbarello M (1999). Role of protease inhibitors in prevention recurrent oral candidiasis in patients with HIV infection: a prospective case-control study. J Acquir Immunodefic Syndr 21: 20-25.
11. Centers for Disease Control Prevention (1994). Revised classification system for human immunodeficiency virus infection in children less than 13years of age. MMWR 43(RR-12):1-10.
12. Cerqueira DF, Portela MB, Pomarico L, Soares RMA, Souza IPR, Castro GF (2010). Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy. Oral Pathol Med 39: 188-194.
13. Cimolai N, Davis J, Trombley C (2002). Candida dubliniensis fungemia and vascular access infection. J Pediatr Hematol Oncol 24: 237-239.
14. European Collaborative Study (1991). Children born to women with HIV-1 infection: natural history and risk of transmission [letter]. Lancet 337: 253.
15. Flanagan MA, Barasch A, Koenigsberg SR, Fine D, Houpt M (2000). Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies. Pediatr Dent 22: 287-291.
16. Giammanco GM, Pizzo G, Pecorella S, Distefano S, Pecoraro V, Milici ME (2002). Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects. Oral Microbiol Immunol 17: 89-94.
17. Grando LJ, Yurgel LS, Machado DC et al (2003). The association between oral manifestations and the socioeconomic and cultural characteristics of HIV-infected children in Brazil and in the United States. Pan Am J Publ Health 14: 112-118.
18. Hoare S (2003). HIV infection in children-impact upon ENT doctors. Int J Pediatr Otorhinolaryngol 67: 585-590.
19. Hoog GS de, Guarro J, Gene J, Figueras MJ (2000). Atlas of clinical fungi, 2nd edn. Centraalbureau voor Schimmelcultures: Utrecht.
20. Jacob LS, Flaitz CM, Nichols CM, Hicks MJ (1998). Role of dentinal carious lesions in the pathogenesis of oral candidosis in HIV infection. J Am Dent Assoc 129: 187-194.
21. Kozinetz CA, Carter AB, Simon C et al (2000). Oral manifestations of pediatric vertical HIV infection. AIDS Patient Care STDS 14: 89-94.
22. Kurzai O, Korting H-C, Harmsen D et al (2000). Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med 78: 521-529.
23. Lorena H (2000). Colonização fúngica da cavidade oral de crianças nascidas de mães soropositivas para HIV no primeiro ano de vida [Dissertação de Mestrado]. Escola Paulista de Medicina da UNIFESP: São Paulo.
24. Madigan A, Murray PA, Houpt M, Catalanotto F, Feuerman M (1996). Caries experience and cariogenic markers in HIV-positive children and their siblings. Pediatr Dent 18: 129-136.
25. Miziara ID, Araujo Filho BC, Weber R (2006). Oral lesions in Brazilian HIV-infected children undergoing HAART. Int J Pediatr Otorhinolaryngol 70: 1089-1096.
26. Naidoo S, Chikte U (2004). Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 10: 13-18.
27. Pincus DH, Coleman DC, Pruitt WR et al (1999). Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 37: 3533-3539.
28. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D (1998). Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 36: 2093-2095.
29. Pongsiriwet S, Iamaroon A, Kanjanavanti S, Pattanaporn K, Krisanoprakornkit S (2003). Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Pediatr Dent 13: 180-185.
30. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW (2000). Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 6: 152-157.
31. Sánchez-Vargas LO, Ortiz-López NG, Villar M et al (2005). Oral Candida isolates colonizing or infecting human immunodeficiency vírus-infected and healthy persons in México. J Clin Microbiol 43: 4159-4162.
32. Sullivan D, Coleman D (1998). Candida dubliniensis: Characteristics and identification. J Clin Microbiol 36: 329-334.
33. World Health Organization (1997). Oral health surveys: basic methods, 4th edn. World Health Organization: Geneva.
34. UNAIDS. 2004 report on the global HIV/AIDS edidemic: 4th global report, Available in: accessed in 19/11/2009.